Academics, Public Interest Groups Warn About "Siloing" Of Gene Test Info
This article was originally published in The Gray Sheet
Executive Summary
Several academic and public interest groups are warning FDA against over-regulation of direct-to-consumer genetic tests and requiring a doctor’s prescription.